{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-079059","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.324089+00:00","generated_at":"2026-06-01T00:45:10.651882+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Janux shareholders elect three Class III directors and ratify EY as auditor","bullets":["Class III directors elected: Vickie Capps, Jay Lichter, and Jake Simson, each with >41 million votes for.","Ernst & Young ratified as independent auditor for FY2024 with 49,801,743 votes for, 1,682 against.","51,850,667 shares outstanding as of record date April 29, 2024; broker non-votes reported for director election.","All proposals passed; no other business items were voted on at the 2024 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-079059","json":"https://secwatch.observer/filing/0000950170-24-079059.json","markdown":"https://secwatch.observer/filing/0000950170-24-079059.md","text":"https://secwatch.observer/filing/0000950170-24-079059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/0000950170-24-079059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000095017024079059/janx-20240626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:45:10.651882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}